REIMBURSEMENT

TASK FORCE

 

 

Overview

 

The purpose of the Digital Pathology Association Reimbursement Task Force is to support the market access of digital pathology solutions globally and drive the value of whole slide imaging (WSI) and AI-based algorithms. The key objectives of the task force are:

  • Drive and shape the model for reimbursement for WSI and AI-based image analysis
  • Support increased market access for DP solutions globally
  • Be the trusted resource (single point of contact) for reimbursement/market access issues for digital pathology
  • Create uniformity in communication around reimbursement for digital pathology solutions
  • Map the reimbursement environment globally and set the strategy for DPA influence

 

Participation in this Task Force is open to Benefactor member representatives only.


Committee Members

 

Chair: Michael Rivers + Paul Gerrard

 

  • Melissa Alexander, MD, PhD, FCAP, AstraZeneca
  • Jennifer Archer, MPP, Artera
  • Jorge Belmonte, Hologic, Inc.
  • Nathan Buchbinder, Proscia Inc.
  • Dawn Cardeiro, MS, Roche
  • Joseph Chiweshe, MD MPH, Leica Biosystems
  • Amanda Coble, PA ASCP, Proscia Inc.
  • Bryan Dangott, MD, Mayo Clinic Florida
  • Dana Dilbeck, Agilent Technologies
  • Paul Gerrard, MD, PathAI
  • Ben Glass, PathAI
  • Samuel Hong, Agilent Technologies
  • David Klimstra, MD, Yale University School of Medicine
  • Vivian Neilley, Google
  • Hong-Phuong Nguyen, Barco, Inc.
  • Anil Parwani, MD, PhD, MBA, Ohio State University Wexner Medical Center
  • Kenneth Philbrick, PhD, Google
  • Michael Rivers, Roche
  • Elizabeth Sheppard, HT(ASCP), MBA, AstraZeneca
  • Timothy Showalter, MD, MPH, Artera
  • Ravinder Singh, CitiusTech
  • Jay Tolley, Mayo Clinic
  • Michelle Wynn, Hologic, Inc.
Chat bot